I2S S.A [ALI2S] vs Lucibel S.A [ALUCI] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: I2S S.A. wins in 13 metrics, Lucibel S.A. wins in 2 metrics, with 0 ties. I2S S.A. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | I2S S.A. | Lucibel S.A. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.57 | -34.79 | I2S S.A. |
| Price-to-Book Ratio | 0.89 | N/A | N/A |
| Debt-to-Equity Ratio | 14.07 | 2,062.00 | I2S S.A. |
| PEG Ratio | N/A | 31.00 | N/A |
| EV/EBITDA | 9.57 | -1.61 | I2S S.A. |
| Profit Margin (TTM) | 3.57% | -30.72% | I2S S.A. |
| Operating Margin (TTM) | 9.96% | -19.34% | I2S S.A. |
| EBITDA Margin (TTM) | 9.96% | N/A | N/A |
| Return on Equity | 5.13% | -261.40% | I2S S.A. |
| Return on Assets (TTM) | 1.97% | -21.37% | I2S S.A. |
| Free Cash Flow (TTM) | $1.84M | $-1.49M | I2S S.A. |
| Dividend Yield | 3.60% | N/A | N/A |
| 1-Year Return | -15.75% | -67.35% | I2S S.A. |
| Price-to-Sales Ratio (TTM) | 0.63 | 0.20 | Lucibel S.A. |
| Enterprise Value | $7.44M | $3.78M | I2S S.A. |
| EV/Revenue Ratio | 0.43 | 0.61 | I2S S.A. |
| Revenue per Share (TTM) | $10 | $41 | Lucibel S.A. |
| Earnings per Share (Diluted) | $0.37 | $-12.09 | I2S S.A. |
| Beta (Stock Volatility) | 0.09 | 0.66 | I2S S.A. |
I2S S.A. vs Lucibel S.A. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| I2S S.A. | -1.57% | -1.55% | -2.31% | 0.00% | -9.29% | -0.78% |
| Lucibel S.A. | 15.65% | 15.12% | -3.88% | -23.85% | -64.52% | -62.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| I2S S.A. | -15.75% | -3.91% | 56.09% | 101.64% | 143.08% | 143.08% |
| Lucibel S.A. | -67.35% | -96.45% | -96.63% | -98.71% | -99.76% | -99.76% |
Performance & Financial Health Analysis: I2S S.A. vs Lucibel S.A.
| Metric | ALI2S | ALUCI |
|---|---|---|
| Market Information | ||
| Market Cap | €10.81M | €1.22M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 17 | 297 |
| 90 Day Avg. Volume | 20 | 251 |
| Last Close | €6.25 | €4.95 |
| 52 Week Range | €5.75 - €7.35 | €2.00 - €18.00 |
| % from 52W High | -14.97% | -72.50% |
| All-Time High | €9.15 (Oct 28, 2024) | €13.88 (Dec 19, 2025) |
| % from All-Time High | -31.69% | -64.34% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | -0.03% |
| Quarterly Earnings Growth | 1.14% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.31% |
| Operating Margin (TTM) | 0.10% | -0.19% |
| Return on Equity (TTM) | 0.05% | -2.61% |
| Debt to Equity (MRQ) | 14.07 | 2,062.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €7.28 | €-4.31 |
| Cash per Share (MRQ) | €3.11 | €1.40 |
| Operating Cash Flow (TTM) | €2.47M | €-983,000 |
| Levered Free Cash Flow (TTM) | €615,968 | €-1,995,500 |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.60% | N/A |
| Last 12-Month Dividend | €0.25 | N/A |
Valuation & Enterprise Metrics Analysis: I2S S.A. vs Lucibel S.A.
| Metric | ALI2S (Apr 24, 2026) | ALUCI (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.57 | -34.79 |
| Forward P/E | N/A | 31.00 |
| PEG Ratio | N/A | 31.00 |
| Price to Sales (TTM) | 0.63 | 0.20 |
| Price to Book (MRQ) | 0.89 | N/A |
| Market Capitalization | ||
| Market Capitalization | €10.81M | €1.22M |
| Enterprise Value | €7.44M | €3.78M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.43 | 0.61 |
| Enterprise to EBITDA | 9.57 | -1.61 |
| Risk & Other Metrics | ||
| Beta | 0.09 | 0.66 |
| Book Value per Share (MRQ) | €7.28 | €-4.31 |
Financial Statements Comparison: I2S S.A. vs Lucibel S.A.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALI2S (2025) | ALUCI (2024) |
|---|---|---|
| Revenue/Sales | 17.00M | 6.34M |
| Cost of Goods Sold | 10.06M | 4.40M |
| COGS % of Revenue | 59.2% | 69.4% |
| Gross Profit | 6.93M | 1.94M |
| Gross Margin | 40.8% | 30.6% |
| Research & Development | N/A | -321,000 |
| Operating Income (EBIT) | 610,406 | -2.65M |
| Operating Margin | 3.6% | -41.7% |
| EBITDA | 863,730 | -1.42M |
| EBITDA Margin | 5.1% | -22.4% |
| Pre-Tax Income | 644,679 | -2.56M |
| Pre-Tax Income % of Revenue | 3.8% | -40.5% |
| Income Tax | 28,711 | -85,000 |
| Income Tax % of Revenue | 0.2% | -1.3% |
| Net Income (Profit) | 615,968 | -3.15M |
| Profit Margin | 3.6% | -49.8% |
Balance Sheet & Liquidity Metrics
| Metric | ALI2S (2025) | ALUCI (2024) |
|---|---|---|
| Cash & Equivalents | 5.24M | 614,000 |
| Total Current Assets | 13.63M | 4.80M |
| Total Current Assets % of Revenue | 80.2% | 75.7% |
| Total Current Liabilities | 5.69M | 4.85M |
| Total Current Liabilities % of Revenue | 33.5% | 76.5% |
| Long-Term Debt | 608,743 | 3.18M |
| Long-Term Debt % of Revenue | 3.6% | 50.2% |
| Total Shareholders Equity | 12.26M | -1.03M |
| Retained Earnings | 615,968 | -3.90M |
| Retained Earnings % of Revenue | 3.6% | -61.5% |
| Property, Plant & Equipment | 2.68M | 1.48M |
Cash Flow Statement Comparison
| Metric | ALI2S (2025) | ALUCI (2024) |
|---|---|---|
| Operating Cash Flow | 2.47M | -2.47M |
| Operating Cash Flow % of Revenue | 14.5% | -39.0% |
| Capital Expenditures | -537,450 | 31,000 |
| Free Cash Flow | 1.84M | -1.49M |
| FCF Margin | 10.8% | -23.5% |
| Debt Repayment | -1.37M | -1.10M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALI2S | ALUCI |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 1.66M | 25.17M |
| Float Shares | N/A | 159,322 |
| % Held by Insiders | 0.00% | 3.62% |
| % Held by Institutions | 1.95% | 0.00% |
| % Held by Public | 98.05% | 96.38% |
Dividend Analysis & Yield Comparison: I2S S.A. vs Lucibel S.A.
| Metric | ALI2S | ALUCI |
|---|---|---|
| Last 12-Month Dividend | €0.25 | N/A |
| Last 12-Month Dividend Yield | 3.60% | N/A |
| 3-Year Avg Annual Dividend | €0.22 | N/A |
| 3-Year Avg Dividend Yield | 2.03% | N/A |
| 3-Year Total Dividends | €0.67 | N/A |
| Ex-Dividend Date | May 29, 2025 | N/A |